62 related articles for article (PubMed ID: 19933702)
1. A new perspective on deoxynivalenol and growth suppression.
Voss KA
Toxicol Sci; 2010 Feb; 113(2):281-3. PubMed ID: 19933702
[No Abstract] [Full Text] [Related]
2. Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation.
Amuzie CJ; Pestka JJ
Toxicol Sci; 2010 Feb; 113(2):412-21. PubMed ID: 19805407
[TBL] [Abstract][Full Text] [Related]
3. Endocrine events prior to puberty in heifers: role of somatotropin, insulin-like growth factor-I and insulin-like growth factor binding proteins.
Armstrong JD; Stanko RL; Cohick WS; Simpson RB; Harvey RW; Huff BG; Clemmons DR; Whitacre MD; Campbell RM; Heimer EP
J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):179-93. PubMed ID: 1285340
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth.
Pass C; MacRae VE; Ahmed SF; Farquharson C
Cell Biochem Funct; 2009 Apr; 27(3):119-27. PubMed ID: 19330796
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
[TBL] [Abstract][Full Text] [Related]
6. [Acromegaly and insulin-like growth factors].
Zapf J; Froesch ER
Schweiz Med Wochenschr; 1986 Jan; 116(3):71-7. PubMed ID: 3945791
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
Hembree JR; Agarwal C; Eckert RL
Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models.
Ransome MI; Turnley AM
Hippocampus; 2008; 18(10):1034-50. PubMed ID: 18566962
[TBL] [Abstract][Full Text] [Related]
9. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
Gradiser M; Matovinovic M; Vrkljan M
Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
12. [Growth hormone insensitivity of rats under the endotoxemic condition].
Wang P; Li N; Li J; Li W
Zhonghua Wai Ke Za Zhi; 2002 Dec; 40(12):940-4. PubMed ID: 12654216
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis.
Dall'Aglio E; Valenti G; Hoffman AR; Zuccarelli A; Passeri M; Ceda GP
Horm Metab Res; 1994 Apr; 26(4):211-2. PubMed ID: 7521856
[No Abstract] [Full Text] [Related]
14. The role of growth hormone in the pathogenesis of diabetic kidney disease.
Flyvbjerg A
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():525-9. PubMed ID: 16444187
[TBL] [Abstract][Full Text] [Related]
15. Expression of growth hormone and insulin-like growth factor in the immune system of children.
Yang Y; Guo L; Ma L; Liu X
Horm Metab Res; 1999 Jun; 31(6):380-4. PubMed ID: 10437628
[TBL] [Abstract][Full Text] [Related]
16. Regulators of cytokine signalling in rheumatoid arthritis.
Rahman A
Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
[No Abstract] [Full Text] [Related]
17. [The cytokine system of bone tissue].
Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR
Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838
[No Abstract] [Full Text] [Related]
18. Insulin-like growth factor I signaling in skeletal muscle and the potential for cytokine interactions.
Adams GR
Med Sci Sports Exerc; 2010 Jan; 42(1):50-7. PubMed ID: 20010130
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and suppressors of cytokine signaling proteins.
Rønn SG; Billestrup N; Mandrup-Poulsen T
Diabetes; 2007 Feb; 56(2):541-8. PubMed ID: 17259405
[No Abstract] [Full Text] [Related]
20. Acquired growth hormone resistance.
Ross RJ; Chew SL
Eur J Endocrinol; 1995 Jun; 132(6):655-60. PubMed ID: 7788000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
